The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(1-(tert-butylcarbamoyl)piperidin-4-yl)-N-(4-(pyrazolo[1,5-a]pyridine-3-carboxamido)phenyl)-1H-indazole-3-carboxamide ID: ALA4483095
PubChem CID: 155539793
Max Phase: Preclinical
Molecular Formula: C32H34N8O3
Molecular Weight: 578.68
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)NC(=O)N1CCC(n2nc(C(=O)Nc3ccc(NC(=O)c4cnn5ccccc45)cc3)c3ccccc32)CC1
Standard InChI: InChI=1S/C32H34N8O3/c1-32(2,3)36-31(43)38-18-15-23(16-19-38)40-27-10-5-4-8-24(27)28(37-40)30(42)35-22-13-11-21(12-14-22)34-29(41)25-20-33-39-17-7-6-9-26(25)39/h4-14,17,20,23H,15-16,18-19H2,1-3H3,(H,34,41)(H,35,42)(H,36,43)
Standard InChI Key: QCSSRHWUDKXXMD-UHFFFAOYSA-N
Molfile:
RDKit 2D
43 48 0 0 0 0 0 0 0 0999 V2000
2.8505 -29.1382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8494 -29.9577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5574 -30.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5556 -28.7293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2642 -29.1346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2690 -29.9532 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0491 -30.2017 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5264 -29.5365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0413 -28.8771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0352 -28.0569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7399 -27.6431 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3245 -27.6536 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3184 -26.8364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0251 -26.4261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0194 -25.6097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3081 -25.2056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6012 -25.6238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6103 -26.4389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3010 -24.3884 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0051 -23.9737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9979 -23.1565 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7163 -24.3760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8095 -25.1877 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6103 -25.3506 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4606 -24.0369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0094 -24.6403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8042 -24.4661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0514 -23.6891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4976 -23.0861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7048 -23.2634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9511 -26.0924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4755 -26.7581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8122 -27.4987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6257 -27.5800 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1014 -26.9144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7636 -26.1674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9629 -28.3244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4869 -28.9886 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7762 -28.4046 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1134 -29.1489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9266 -29.2291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6374 -29.8132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3234 -29.9348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 6 1 0
5 4 1 0
4 1 2 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 2 0
9 10 1 0
10 11 2 0
10 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
19 20 1 0
20 21 2 0
20 22 1 0
22 23 2 0
23 24 1 0
24 26 1 0
25 22 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 25 1 0
31 32 1 0
31 36 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
24 31 1 0
34 37 1 0
37 38 2 0
37 39 1 0
39 40 1 0
40 41 1 0
40 42 1 0
40 43 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 578.68Molecular Weight (Monoisotopic): 578.2754AlogP: 5.33#Rotatable Bonds: 5Polar Surface Area: 125.66Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 3CX Acidic pKa: ┄CX Basic pKa: 0.91CX LogP: 3.72CX LogD: 3.72Aromatic Rings: 5Heavy Atoms: 43QED Weighted: 0.26Np Likeness Score: -1.59
References 1. O'Malley DP, Ahuja V, Fink B, Cao C, Wang C, Swanson J, Wee S, Gavai AV, Tokarski J, Critton D, Paiva AA, Johnson BM, Szapiel N, Xie D.. (2019) Discovery of Pyridazinone and Pyrazolo[1,5-a]pyridine Inhibitors of C-Terminal Src Kinase., 10 (10): [PMID:31620238 ] [10.1021/acsmedchemlett.9b00354 ]